MedinCell S.A.
MDCLF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $231 | $205 | $182 | $188 |
| - Cash | $23 | $59 | $32 | $19 |
| + Debt | $68 | $59 | $60 | $59 |
| Enterprise Value | $276 | $205 | $210 | $227 |
| Revenue | $14 | $16 | $9 | $4 |
| % Growth | -15.4% | 70.7% | 150.6% | – |
| Gross Profit | $0 | $16 | $9 | $3 |
| % Margin | 0% | 100% | 100% | 91.3% |
| EBITDA | -$17 | -$4 | -$7 | -$12 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |
| Net Income | -$19 | -$4 | -$15 | -$17 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS Diluted | -0.57 | -0.13 | -0.5 | -0.58 |
| % Growth | -338.5% | 74% | 13.8% | – |
| Operating Cash Flow | -$17 | -$3 | $22 | -$0 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$17 | -$4 | $21 | -$0 |